Those observations might suggest that the CD38 enzymatic hydrolysis product cADPR, either from tumor cells or immune cells, might both play an important role for tumor proliferation, formation and migration independent of regulating NAD+ or adenosine in solid TME. The gene discussed is CD38; the disease is neoplasm.